top of page

BIO Ventures for Global Health

BIO Ventures for Global Health (BVGH) is a non-profit organization based in Seattle, USA that forges and manages multinational public-private partnerships across infectious and non-communicable diseases to build clinical trial and early-stage research and development (R&D) capacity; catalyze innovative R&D; and expand access to quality healthcare in low- and middle-income countries (LMICs)—with a focus on Africa.
 

BVGH.png

Founded in 2003, BVGH brings decades of scientific training, project management expertise, and biotechnology and pharmaceutical industry experience to partnership development and execution. BVGH’s programs include the African Access Initiative (AAI), African Consortium for Cancer Clinical Trials (AC³T), and Global Innovation Alliance (GIA). GIA builds upon BVGH’s experience and successes in co-leading initiatives including the Pool for Open Innovation Against Neglected Tropical Diseases (POINT) and WIPO Re:Search.

This project is supported by the Global Health EDCTP3 Joint Undertaking and its members, the European Union and the EDCTP Association. (Grant Agreement No 101103299)

edctp3-global-health-logo.png
Flag-European-Union.webp
bottom of page